MARKET

JNJ

JNJ

Johnson & Johnson
NYSE
155.50
+2.39
+1.56%
After Hours: 155.70 +0.2 +0.13% 19:03 11/21 EST
OPEN
153.62
PREV CLOSE
153.11
HIGH
156.06
LOW
152.81
VOLUME
10.14M
TURNOVER
--
52 WEEK HIGH
168.85
52 WEEK LOW
140.91
MARKET CAP
374.39B
P/E (TTM)
25.70
1D
5D
1M
3M
1Y
5Y
1D
Zevra Niemann-Pick disease type C drug Miplyffa now available
Seeking Alpha · 10h ago
Eli Lilly Stock: Unexpected Developments (Rating Downgrade)
Seeking Alpha · 11h ago
Johnson & Johnson Announces Health Canada Authorizes CARVYKTI For Patients With Relapsed Or Refractory Multiple Myeloma Who Have Received 1-3 Prior Lines Of Therapy, Including A Proteasome Inhibitor And An Immunomodulatory Agent, And Who Are Refractory To Lenalidomide
Benzinga · 11h ago
Merck Stock Trades Near 52-Week Low: What's Next for Investors?
NASDAQ · 12h ago
Optimism over global healthcare sector rises: Jefferies
Seeking Alpha · 14h ago
Price Over Earnings Overview: Johnson & Johnson
Benzinga · 19h ago
Johnson & Johnson’s Promising Pharmaceutical Developments Justify Buy Rating
TipRanks · 1d ago
Of 63 Fortune 500 Industry Leaders, 57 Pay Dividends, 38 Are Cash Rich And 1 Is A Buy
Seeking Alpha · 1d ago
More
About JNJ
Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company's primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. Products in this segment are distributed directly to retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment includes a broad portfolio of products used in the orthopedic, surgery, interventional solutions, cardiovascular intervention, and vision fields. The MedTech segment also offers a commercially available intravascular lithotripsy (IVL) platform for coronary artery disease (CAD) and peripheral artery disease (PAD).

Webull offers Johnson & Johnson stock information, including NYSE: JNJ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JNJ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading JNJ stock methods without spending real money on the virtual paper trading platform.